Jul 19 |
Shuttle Pharma’s Selective HDAC Inhibitor Exhibits ATM Activation and Modulation of ER Expression Resulting in Substantial Growth Inhibition of Estrogen Receptor Positive Breast Cancer Cells, as Reported in PLOS ONE
|
Jun 18 |
Shuttle Pharma names Timothy Lorber as CFO
|
Jun 18 |
Shuttle Pharma Appoints Timothy Lorber as Chief Financial Officer
|
May 22 |
Shuttle Pharma to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024
|
May 14 |
Shuttle Pharmaceuticals reports Q1 results
|
May 14 |
Shuttle Pharma Provides First Quarter 2024 Corporate Update
|
Apr 29 |
Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV
|
Apr 23 |
Shuttle Pharmaceuticals to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024
|
Apr 5 |
Shuttle Pharmaceuticals files to sell subscription rights to buy $4.5M in units
|
Apr 3 |
Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on April 4, 2024
|